Abstract: The present invention provides multiphasic systems comprising at least one chiral selector and an achiral phase transfer catalyst, wherein said system can be used to effect enantioselective reactions or asymmetric induction reactions.

Abstract: The invention relates to a chiral selector useful in separating underivatized enantiomers of nonsteroidal anti-inflammatory agents, particularly naproxen and other arylacetic acid compounds, and relates to a process for achieving such separation utilizing the chiral selector, which is also useful in achieving the enantiomeric separation of amines, alcohol derivatives, epoxides and sulfoxides. The invention is also directed to an apparatus which comprises the chiral selectors.

Abstract: The present invention relates to the separation of .beta.-amino alcohol compounds, particularly compounds known as .beta.-blockers, by employing what is known as a chiral selector compound which can achieve separation of enantiomers without requiring derivatization of the enantiomers before effecting separation.

Abstract: Carbon clusters, such as C.sub.60 and C.sub.70 fullerenes are separated by means of a recognition selector having the formula: ##STR1## wherein R.sub.1 is ##STR2## wherein R.sub.2 is O, S or NR.sub.12 wherein R.sub.12 is independently hydrogen or P.dbd.O with the proviso that when R.sub.12 is P.dbd.O, then only one such group is present and all R.sub.2 's are additionally bonded to R.sub.12,R.sub.4 is independently O, S or NH,R.sub.3 and R.sub.5 are each independently hydrogen or lower alkyl,n and o are each independently zero, 1, 2 or 3,p, q, r, s and t are each independently zero or 1,Ar is a monocyclic or ortho-fused polycyclic aromatic moiety having up to 10 carbon atoms, either of which may be unsubstituted or substituted with one or more lower alkyl, NO.sub.2, N(R.sub.6).sub.3.sup.30, CN COOR.sub.7, SO.sub.3 H, COR.sub.8 and OR.sub.9 wherein R.sub.6, R.sub.7, R.sub.8 and R.sub.9 are each independently hydrogen or lower alkyl;W is H or CH.dbd.CH.sub.2 ; andm is 1 to 10.

Abstract: The invention relates to a chiral selector useful in separating underivatized enantiomers of nonsterodial anti-inflammatory agents, particularly naproxen and other arylacetic acid compounds, and relates to a process for achieving such separation utilizing the chiral selector, which is also useful in achieving the enantiomeric separation of amines, alcohol derivatives, epoxides and sulfoxides. The invention is also directed to an apparatus which comprises the chiral selectors.

Abstract: A high performance chiral selector having the formula: ##STR1## wherein Ar is a monocyclic or ortho-fused polycyclic aromatic moiety having up to 10 ring carbon atoms, either of which may be unsubstituted or substituted with one or more C.sub.1 to C.sub.6 alkyl, C.sub.1 to C.sub.6 alkoxy, NO.sub.2, N(R.sub.5).sub.3.sup.+, CN, COOR.sub.6 SO.sub.3 H and COR.sub.7 groups wherein R.sub.5, R.sub.6 and R.sub.7 are each independently hydrogen or C.sub.1 to C.sub.6 alkyl;R.sub.1 and R.sub.2 are each independently hydrogen, C.sub.1 to C.sub.6 alkyl or phenyl;R.sub.3 and R.sub.4 are each independently C.sub.1 to C.sub.12 alkyl or C.sub.2 to C.sub.12 alkenyl; andm and n are each independently zero or 1, said compound being an R or an S enantiomer or a mixture of R and S enantiomers.

Abstract: The invention relates to a chiral selector useful in separating underivatized enantiomers of nonsterodial anti-inflammatory agents, particularly naproxen and other arylacetic acid compounds, and relates to a process for achieving such separation utilizing the chiral selector, which is also useful in achieving the enantiomeric separation of amines, alcohol derivatives, epoxides and sulfoxides. The invention is also directed to an apparatus which comprises the chiral selectors.

Abstract: Carbon clusters, such as C.sub.60 and C.sub.70 fullerenes are separated by means of a recognition selector having the formula: ##STR1## wherein R.sub.1 is ##STR2## wherein R.sub.2 is O, S or NR.sub.12 wherein R.sub.12 is independently hydrogen or P.dbd.O with the proviso that when R.sub.12 is P.dbd.O, then only one such group is present and all R.sub.2 's are additionally bonded to R.sub.12,R.sub.4 is independently O, S or NH,R.sub.3 and R.sub.5 are each independently hydrogen or lower alkyl,n and o are each independently zero, 1, 2 or 3,p, q, r, s and t are each independently zero or 1,Ar is a monocyclic or ortho-fused polycyclic aromatic moiety having up to 10 carbon atoms, either of which may be unsubstituted or substituted with one or more lower alkyl, NO.sub.2, N(R.sub.6).sub.3.sup.+, CN, COOR.sub.7, SO.sub.3 H, COR.sub.8 and OR.sub.9 wherein R.sub.6, R.sub.7, R.sub.8 and R.sub.9 are each independently hydrogen or lower alkyl;W is H or CH.dbd.CH.sub.2 ; andm is 1 to 10.

Abstract: A high performance chiral selector having the formula: ##STR1## wherein Ar is a monocyclic or ortho-fused polycyclic aromatic moiety having up to 10 ring carbon atoms, either of which may be unsubstituted or substituted with one or more C.sub.1 to C.sub.6 alkyl, C.sub.1 to C.sub.6 alkoxy, NO.sub.2, N(R.sub.5).sub.3.sup.+, CN, COOR.sub.6, SO.sub.3 H and COR.sub.7 groups wherein R.sub.5, R.sub.6 and R.sub.7 are each independently hydrogen or C.sub.1 to C.sub.6 alkyl;R.sub.1 and R.sub.2 ar each independently hydrogen, C.sub.1 to C.sub.6 alkyl or phenyl;R.sub.3 and R.sub.4 are each independently C.sub.1 to C.sub.12 alkyl or C.sub.2 to C.sub.12 alkenyl; andm and n are each independently zero or 1, said compound being an R or an S enantiomer or a mixture of R and S enantiomers.

Abstract: The invention relates to a chiral selector useful in separating underivatized enantiomers of nonsterodial anti-inflammatory agents, particularly naproxen and other arylacetic acid compounds, and relates to a process for achieving such separation utilizing the chiral selector, which is also useful in achieving the enantiomeric separation of amines, alcohol derivatives, epoxides and sulfoxides. The invention is also directed to an apparatus which comprises the chiral selectors.

Abstract: The invention relates to a process for the high yield, cost efficient means of separating enantiomers. The process utilizes a supported liquid membrane and a chiral carrier which selectively complexes with one of the two enantiomeric optical configurations. The invention is also directed to an apparatus adaptable to the continuous and staged separation of enantiomers. In one embodiment, the apparatus utilizes a semi-permeable barrier and source and receiving locations each of which may be kept at temperatures which facilitate the complexation and dissociation processes.